NTLA icon

Intellia Therapeutics

363 hedge funds and large institutions have $8.34B invested in Intellia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 130 increasing their positions, 113 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more call options, than puts

Call options by funds: $ | Put options by funds: $

6.79% less ownership

Funds ownership: 91.42%84.63% (-6.8%)

17% less capital invested

Capital invested by funds: $10B → $8.34B (-$1.68B)

33% less funds holding in top 10

Funds holding in top 10: 128 (-4)

Holders
363
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$99.9M
Puts
$94M
Net Calls
Net Calls Change

Top Buyers

1 +$79.1M
2 +$75.9M
3 +$60.6M
4
Morgan Stanley
Morgan Stanley
New York
+$60.1M
5
Victory Capital Management
Victory Capital Management
Texas
+$50.4M

Top Sellers

1 -$149M
2 -$126M
3 -$97.6M
4
NAMA
Nikko Asset Management Americas
New York
-$89.1M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$54M
Name Holding Trade Value Shares
Change
Change in
Stake
276
$268K
277
$268K
278
$267K
279
$258K
280
$255K
281
$255K
282
$251K
283
$249K
284
$248K
285
$245K
286
$243K
287
$239K
288
$238K
289
$227K
290
$225K
291
$222K
292
$219K
293
$215K
294
$203K
295
$201K
296
$201K
297
$196K
298
$189K
299
$163K
300
$156K